...
首页> 外文期刊>AIDS care. >Evaluation of the consistency of refills for antiretroviral medications in two hospitals in the state of Rio de Janeiro, Brazil.
【24h】

Evaluation of the consistency of refills for antiretroviral medications in two hospitals in the state of Rio de Janeiro, Brazil.

机译:在巴西里约热内卢州的两家医院中对抗逆转录病毒药物补充剂的一致性进行评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We conducted a retrospective cohort study using pharmacy records to assess the frequency of delay in picking up antiretroviral (ARV) medication refills from the pharmacy and to identify determinants of delay among HIV-infected patients at two Brazilian hospitals. We selected patients who were on ARV therapy before January 2001 at Nova Iguacu Hospital (NIPRH) (N = 265) and Evandro Chagas (N=424) Clinical Research Institute. We abstracted medical records and pharmacy data using standardised forms and analysed potential associations between delay in refilling medications and patients' demographic characteristics, type of ARV drug regimen and evolution of HIV disease. Sixty-nine patients (26%) had delays in medication refills >1 month at least once in 2001 at NIPRH compared with 140 (33%) patients at IPEC (p=0.052). No factor was found to be associated with having a delay in medication refill >1 month at NIPRH. At IPEC, delays in medication refill >1 month were associated with a median CD4+ T cell count <200/mm(3) versus >500/mm(3) (adjusted odds ratio (AOR) = 3.8; 95% confidence interval (CI) =1.6-8.9) and with dual protease inhibitor-based ARV regimens versus other regimens (AOR = 4.3; 95% CI = 1.9-9.4). In conclusion, rates of delay in medication refills were similar to rates of adherence to ARV therapy found in other studies in Brazil, suggesting that delay in medication refills could be used as a surrogate for adherence. Analysing ARV medication refills can complement self-reported information on adherence.
机译:我们使用药房记录进行了一项回顾性队列研究,评估了从药房购买抗逆转录病毒(ARV)药物补充剂的延迟频率,并确定了两家巴西医院感染HIV的患者中延迟的决定因素。我们选择了2001年1月之前在Nova Iguacu医院(NIPRH)(N = 265)和Evandro Chagas(N = 424)临床研究所接受抗逆转录病毒疗法的患者。我们使用标准化表格提取了病历和药房数据,并分析了补充药物的延误与患者的人口统计学特征,抗逆转录病毒药物治疗方案的类型以及艾滋病病毒感染之间的潜在关联。 2001年,在NIPRH中有69名患者(26%)的药物补充延迟至少一次超过1个月,而在IPEC中则有140名患者(33%)延迟(p = 0.052)。在NIPRH,没有发现与药物补充延迟超过1个月有关的因素。在IPEC,药物补充延迟超过1个月与CD4 + T细胞计数中位数<200 / mm(3)与> 500 / mm(3)相关(校正比值比(AOR)= 3.8; 95%置信区间(CI) )= 1.6-8.9),以及基于双蛋白酶抑制剂的ARV方案与其他方案(AOR = 4.3; 95%CI = 1.9-9.4)。总之,药物补充的延迟率与巴西其他研究中对ARV治疗的依从率相似,这表明药物补充的延迟可以用作依从性的替代。分析ARV药物补充剂可以补充自我报告的依从性信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号